术后早期DN4评分阳性可预测持续性术后神经病理性疼痛风险增加
这项多中心前瞻性观察研究纳入593例接受13种手术的患者,用DN4问卷评估术后急性神经病理性疼痛,用DN2问卷评估术后2个月持续性术后神经病理性疼痛(PPSNP)。术后第2天12.9%患者存在急性神经病理性疼痛,2个月时33.3%可评估患者存在PPSNP;术后当天或第2天DN4≥4/10是PPSNP的显著危险因素(OR 4.22,95%CI 2.19–8.12)。
要点
- 术后当天和/或第2天DN4≥4/10提示PPSNP风险显著升高(OR 4.22)。
- 术后第2天急性神经病理性疼痛发生率为12.9%(95%CI 9.7–16.7)。
- 术后2个月PPSNP在可评估患者中占33.3%。
核心结论
- 术后早期急性神经病理性疼痛显著增加持续性术后神经病理性疼痛的风险。
主要发现
- 593例中41.2%术前有疼痛,8.2%描述为神经病理性疼痛。
- 术后当天72.2%、第2天71.3%患者经历急性疼痛;神经病理性疼痛比例分别为5.6%(95%CI 3.6–8.3)和12.9%(95%CI 9.7–16.7)。
- 术后2个月,333例可评估患者中PPSNP占33.3%。
- 多因素分析显示术后当天或第2天DN4≥4/10是PPSNP的显著危险因素(OR 4.22,95%CI 2.19–8.12)。
关键数值与推荐
- 急性术后神经病理性疼痛定义为术后当天和/或第2天DN4评分≥4/10。
- 持续性术后神经病理性疼痛定义为术后2个月DN2评分≥3/7。
- 疼痛评估使用10分数字评定量表,评分>0时进一步用DN4或DN2问卷评估神经病理性疼痛。
临床怎么用
- 术后早期可用DN4问卷识别急性神经病理性疼痛患者,这类患者PPSNP风险较高,应加强随访。
- 对术后当天或第2天DN4≥4/10者,可在术后2个月用DN2问卷筛查PPSNP。
局限性
- 229例(38.6%)和260例(43.8%)患者分别在术后1个月和2个月无法联系评估,可能影响PPSNP发生率估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute neuropathic pain can occur in the postoperative period but any link with persistent post-surgical neuropathic pain remains unclear. OBJECTIVES: The objectives of this study were to prospectively describe the incidence of acute post-surgical neuropathic pain in a large population using the DN4 (clinician administered) questionnaire and to confirm the hypothetical link between acute and persistent neuropathic pain at 2 months after surgery in a large population using the DN2 (self administered) questionnaire. DESIGN: A multi-centre, prospective and observational trial. SETTING: Two consecutive days in 27 hospitals in France. PATIENTS: Six hundred and eight patients undergoing 13 different types of surgery. Fifteen patients were excluded as data were incomplete, and 229 (38.6%) and 260 (43.8%) were not contactable for assessment at 1 and 2 months after surgery, respectively. MAIN OUTCOME MEASURES: Pain was evaluated at least 2 h postoperatively on the same day (D0),on the second day (D2) and at 1 and 2 months after surgery (M1 and M2). Pain was assessed using a 10-point Numeric Rating Scale. If the Numeric Rating Scale score was greater than 0, neuropathic pain was assessed using a DN4 (clinician administered) questionnaire or using a DN2 (self-administered) questionnaire. Acute and persistent postsurgical neuropathic pain (PPSNP) were defined respectively by a DN4 score at least 4/10 on day 0 and/or day 2 and a DN2 score at least 3/7 at 2 months after surgery. RESULTS: Of the 593 patients included, 41.2% were in pain before surgery and 8.2% described neuropathic pain. Early after surgery, the majority of the 593 patients (72.2% on the day of surgery and 71.3% on day 2) experienced acute pain. It was neuropathic in nature in 5.6% of patients (95% CI, 3.6 to 8.3) on the day of surgery and 12.9% (95% CI, 9.7 to 16.7) on day 2. Two months after surgery, PPSNP was present in 33.3% of the 333 patients assessed. Multivariate analysis showed that a DN4 score at least 4/10 on the day of surgery or on day 2 was a significant risk factor for PPSNP [odds ratios 4.22 (95% CI, 2.19 to 8.12)]. CONCLUSION: Our results suggest that early acute postsurgical neuropathic pain significantly increases the risk of persistent post-surgical neuropathic pain. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NTC NCT02826317.
引用
- Beloeil H, Sion B, Rousseau C, et al. Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anaesthesiol. 2017. PMID: 28437260. doi:10.1097/EJA.0000000000000634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。